On April 26, 2024, Medifron DBT Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,190 KRW | +3.30% | -2.45% | -19.93% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,190 KRW | +3.30% | -2.45% | 53.8M | ||
1,443 KRW | -4.12% | -3.93% | 89.42M | ||
1st Jan change | Capi. | |
---|---|---|
-19.93% | 53.8M | |
+19.29% | 7.29B | |
-17.11% | 1.77B | |
-5.59% | 1.26B | |
-17.35% | 1.07B | |
+1.72% | 578M | |
-47.34% | 505M | |
-33.57% | 486M | |
+16.79% | 467M | |
-33.05% | 374M |
- Stock Market
- Equities
- A214270 Stock
- News FSN Co., Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd.